# Vilon — dosage, half-life & reference guide | PepVault

Source: https://pepvault.app/peptides/vilon

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Healing & recovery](https://pepvault.app/peptides#healing)

# Vilon Dosage, half-life & reference guide

Also known as Lys-Glu · KE dipeptide · Lysylglutamic acid

Reviewed November 2026 Evidence: Emerging [Published by PepVault](https://pepvault.app/guides/how-we-research)

A two-amino-acid peptide (Lys-Glu) from the Russian bioregulator program and one of the active parts of the thymus extract Thymalin. In lab studies it switched silenced genes back on in lymphocytes from old people, and in old rats it raised sexual function; small Russian studies in people with type 1 diabetes, with no placebo group, report calmer blood clotting and less insulin needed.

- **How often:** Daily
- **Half-life:** Unknown
- **Evidence:** Emerging
- **Routes:** SubQ, Oral capsules

No controlled study has set a dose of Vilon: the amounts people run are their own protocol, not a reference.

## How it works.

A dipeptide, Lys-Glu (KE), from Vladimir Khavinson's St. Petersburg bioregulator program and one of the active parts of the thymus extract Thymalin; Russian papers call it thymomimetic, a peptide that acts like the thymus on the immune system. In lymphocytes from old people grown in the lab it loosened tightly packed chromatin, which its developers read as switching silenced genes back on, and in old male rats it raised sexual function and lowered prolactin. In people with type 1 diabetes, small Russian studies with no placebo group report calmer blood clotting and, in most, less insulin needed. Almost all of the research is by its developers.

**Commonly reported:** Little to feel during a short course; it is often run beside Epitalon.

<!--promo-->

PepVault for iPhone

## Track vilon in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Where Vilon works.

- ### Immune system

  **In the lab.** Russian papers call it thymomimetic, a peptide that acts like the thymus on the immune system.
- ### Appetite & metabolism

  **In people.** In people with type 1 diabetes, small Russian studies with no placebo group report calmer blood clotting and, in most, less insulin needed.

An area lights for what a peptide is used for and what people report, with the evidence beside it. It isn’t a promise that it works there.

## Week by week.

What to expect in the first 8 weeks

- **Onset:** Not established (no controlled timing data)
- **Peak effect:** Not established
- **Duration:** Courses of 5–10 days (community practice)

1. Day 1–10 Community

   ### A short pulse, not a daily habit

   Vilon is run in short courses of about a week, then left for months. Commonly reported: little to feel during the course; some notice mild soreness where it goes in, or an unsettled stomach with capsules.

   Updated Nov 2026
2. Day 10–60 Clinical

   ### Where its human studies looked

   Vilon's human studies are in type 1 diabetes, and they measured blood: calmer clotting markers and, in most patients, less insulin needed. If you track glucose, the weeks after a course are a reasonable time to look, and worth raising with your clinician if you use insulin.

   The science

   Kuznik 2006: in type 1 diabetes, Vilon (Lys-Glu) added to treatment significantly reduced or removed signs of chronic DIC (clotting activation), with less effect in elderly patients with severe disease. Kuznik 2007: antithrombin III and protein C rose, fibrinolysis was stimulated, and in most cases the insulin dose needed fell. Neither had a placebo group.

   Sources

   - Kuznik et al. (2006)
   - Kuznik et al. (2007)

   Updated Nov 2026
3. Any day Animal

   ### What Vilon is built on

   A dipeptide from the Russian bioregulator program and one of the active parts of the thymus extract Thymalin. In lymphocytes from old people it switched silenced genes back on, and in old rats it raised sexual function; its human studies are small Russian ones without a placebo group.

   The science

   KE and EW are active substances of Thymalin (Linkova 2023). Lezhava 2004: in cultured lymphocytes from old people, Vilon unrolled facultative heterochromatin and reactivated ribosomal genes, without touching pericentromeric heterochromatin. Kudriavtseva 2006: in old hemigonadectomized male rats, regular Vilon activated sexual function and lowered prolactin, LH and ACTH changed. Kuznik 2006 and 2007: type 1 diabetes, no placebo group.

   Sources

   - Linkova et al. (2023)
   - Lezhava et al. (2004)
   - Kudriavtseva et al. (2006)
   - Kuznik et al. (2006)
   - Kuznik et al. (2007)

   Updated Nov 2026
4. With Epitalon Community

   ### The thymus and pineal pair

   Vilon is often run beside Epitalon, the thymus peptide with the pineal one, echoing the long Russian study that gave the thymus and pineal extracts together. No study has tested Vilon with Epitalon.

   The science

   The pairing is community and protocol practice. Its root is Khavinson and Morozov 2003, where the thymus extract Thymalin with the pineal extract Epithalamin reported the largest drop in deaths among 266 older adults followed 6–8 years, against a control group; Vilon is one of Thymalin's active parts (Linkova 2023).

   Sources

   - Khavinson et al. (2003)
   - Linkova et al. (2023)

   Updated Nov 2026
5. With Thymalin Community

   ### Already inside Thymalin

   Vilon is one of the active parts of Thymalin, so running both doubles up on the same dipeptide. No study has tested the pair.

   The science

   KE (Vilon) and EW (Thymogen) are active substances of Thymalin (Linkova 2023).

   Sources

   - Linkova et al. (2023)

   Updated Nov 2026

Day 1 is the day you start it.

No placebo-controlled study of Vilon exists. Timelines are what users commonly report; the mechanism comes from lab studies of human cells and from rats, and the human data are small Russian studies with no placebo group.

Preliminary research

## More on vilon

### Compared with

- [Thymalin vs Vilon](https://pepvault.app/peptides/compare/thymalin-vs-vilon)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How the vial count works](https://pepvault.app/peptide-vial-tracker-app)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Bioregulator (Khavinson peptide)](https://pepvault.app/glossary/bioregulator)

## A typical run.

### Run notes

- **Cycle:** Run in short courses rather than continuously, like the other bioregulators: community courses run about 5–10 days, a few times a year. No study has tested a course length. Community practice — opinions vary. Not a clinical recommendation.
- **Timing:** No timing has been studied.
- **Routes:** SubQ injection, Oral capsules
- **Stacks:** Epitalon, Thymalin

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-next-mixing&mt=8)

<!--/promo-->

## Safety.

### Common side effects

- Injection-site discomfort
- Mild stomach upset (capsules)

#### Interactions

No interaction studies exist. In a Russian study of people with type 1 diabetes, most needed less insulin while on Vilon, so insulin and other glucose-lowering medicines are worth raising with your clinician, as are blood thinners, since the same studies measured changes in clotting.

### Safety notes

No study has looked at the safety of Vilon on its own, and its long-term effects are unknown. Discuss with your clinician before use, particularly during pregnancy or breastfeeding, with an autoimmune condition, or with diabetes treated with insulin.

## Goes with.

- [Epitalon](https://pepvault.app/peptides/epitalon)
- [Thymalin](https://pepvault.app/peptides/thymalin)

## One question at a time.

- [Side effects](https://pepvault.app/peptides/vilon/side-effects)
- [How long it takes to work](https://pepvault.app/peptides/vilon/how-long-to-work)
- [Legal status](https://pepvault.app/peptides/vilon/legal-status)
- [The bioregulator family](https://pepvault.app/bioregulators)

## Compared with.

- [Thymalin vs Vilon](https://pepvault.app/peptides/compare/thymalin-vs-vilon)

## Questions people ask.

### What is Vilon?

A two-amino-acid peptide (Lys-Glu) from the Russian bioregulator program and one of the active parts of the thymus extract Thymalin. In lab studies it switched silenced genes back on in lymphocytes from old people, and in old rats it raised sexual function; small Russian studies in people with type 1 diabetes, with no placebo group, report calmer blood clotting and less insulin needed.

### How is Vilon dosed in research?

The library carries no reference dose for Vilon. No controlled study has set a dose of Vilon: the amounts people run are their own protocol, not a reference.

### How long does Vilon last?

The half-life of Vilon is unknown (never measured).

### What do people report on Vilon?

Commonly reported on Vilon: little to feel during a short course; it is often run beside Epitalon.

### Is Vilon safe?

The research basis for Vilon is emerging: primarily preclinical / limited human data. Common side effects in the library: injection-site discomfort and mild stomach upset (capsules).

### What does Vilon stack with?

Common stacks for Vilon: Epitalon and Thymalin.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-next-questions&mt=8)

<!--/promo-->

## Research.

The literature

### Search the latest research

[PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=Vilon) [Google Scholar](https://scholar.google.com/scholar?q=Vilon)

## Reference.

- **Cadence:** Daily
- **Half-life:** Unknown Unknown (never measured)
- **Research basis:** Emerging Primarily preclinical / limited human data

## More healing & recovery peptides

- [Thymosin Beta-4 2–2.5 mg](https://pepvault.app/peptides/thymosin-beta-4)
- [LL-37 100–300 mcg](https://pepvault.app/peptides/ll-37)
- [Larazotide 0.5–1 mg](https://pepvault.app/peptides/larazotide)
- [Linaclotide 72–290 mcg](https://pepvault.app/peptides/linaclotide)
- [VIP 50 mcg](https://pepvault.app/peptides/vip)
- [ARA-290 1–4 mg](https://pepvault.app/peptides/ara-290)

## Free tools

- [Injection guide (3D)](https://pepvault.app/lab/injection)
- [Peptide Sky (3D)](https://pepvault.app/lab/sky)
- [Peptide tier list](https://pepvault.app/lab/tiers)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Track vilon in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track vilon in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on vilon

### Compared with

- [Thymalin vs Vilon](https://pepvault.app/peptides/compare/thymalin-vs-vilon)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How the vial count works](https://pepvault.app/peptide-vial-tracker-app)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Bioregulator (Khavinson peptide)](https://pepvault.app/glossary/bioregulator)

<!--promo-->

PepVault for iPhone

## Track vilon in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

Reviewed November 2026 [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
